Ingrezza — Medica
Chorea associated with Huntington’s disease
Initial criteria
- age ≥ 18 years
- Diagnosis of Huntington’s disease confirmed by genetic testing (for example, expanded HTT CAG repeat sequence of at least 36)
- Prescribed by or in consultation with a neurologist
Approval duration
1 year